Approximate cost: $8,000 per year
CVS CAREMARK Pharmacy, in partnership with Mylan Pharmaceuticals, is currently the exclusive pharmacy distributor for Cystagon capsules. Cystagon has been approved by the U.S. FDA for the management of nephrotic cystinosis in children and adults.
Cystagon is available in
50 mg oral capsules
150 mg oral capsules
To find out more about CVS Caremark call 1-800-238-7828.
Cystagon® is a registered trademark of Mylan Pharmaceuticals Inc.
Approximate cost: $250,000 per year
PROCYSBI is a delayed-release form of cysteamine bitartrate that works by continuously reducing the toxic levels of cystine in the cells. This may help prevent irreversible cellular damage. PROCYSBI can provide continuous control of cystine when taken every 12 hours.
Prescribing information: http://www.procysbi.com/docs/Procysbi-Full-Prescribing-Information.pdf
- An oral (gel capsule) form of cysteamine (not yet available)
- In addition to the oral formulation to treat acute exacerbations in cystic fibrosis, NovaBiotics has formulated dry powder inhalable forms as a maintenance therapy for chronic use. This form of targeted delivery is being developed in order to deliver maximum efficiency locally within the lung.
- Being developed by NovaBiotics, Ltd. (UK Company)
- Lynovex link on NovaBiotics website:
Info from the NovaBiotics website regarding Lynovex: